Collegium Pharmaceutical Inc (COLL)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 228,842 | 195,431 | 194,842 | 202,928 | 186,031 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $228,842K)
= 0.00
The debt-to-capital ratio for Collegium Pharmaceutical Inc has consistently remained at 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not utilized debt in its capital structure during this period. A low or zero debt-to-capital ratio can suggest that Collegium Pharmaceutical Inc is primarily financed through equity, which may indicate a lower financial risk as the company is not reliant on debt to fund its operations and investments. However, it is essential to consider other financial metrics and factors to gain a holistic understanding of the company's financial health and performance.
Peer comparison
Dec 31, 2024